Breaking News
Get 55% Off 0
🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREE
Watch Now
Close

Exicure Inc (XCUR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Exicure's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.2200 +0.2200    +7.33%
12/11 - Closed. Currency in USD
After Hours
3.3300
+0.1100
+3.4161%
18:07:42 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 107,586
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 2.9400 - 3.3800
Exicure 3.2200 +0.2200 +7.33%

Exicure Inc Company Profile

 
Get an in-depth profile of Exicure Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

6

Equity Type

ORD

Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Contact Information

Address 2430 North Halsted Street
Chicago, 60614
United States
Phone 847 673 1700
Fax 847 556 6411

Top Executives

Name Age Since Title
Hojoon Lee 49 2023 Director
Minhee Eom 57 2023 Independent Director
Dongho Lee 62 2023 Independent Director
Michael R. Hodges - - Member of Advisory Board
Amy S. Paller - - Member of Advisory Board
Henry Paulson - 2019 Member of Advisory Board
Hyuk Joon Ko 56 2023 Independent Director
Paul Kang 62 2023 CEO, President & Director
Jiyoung Hwang 47 2023 CFO, Secretary & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XCUR Comments

Write your thoughts about Exicure Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Anthony Morrow
Note7Creole Feb 06, 2024 4:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a be careful ticker
Nhat Doan
Nhat Doan Dec 20, 2022 4:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
∆ SYMBOLS that can not be SHORT 👉 NEVER BUY (Trap) 👈 Must DELETE FOREVER. 🥰🤩👍👹💣👍∆
Jean Mercredi
Jean Mercredi Jun 30, 2022 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is this?
Zafer Yamak
Zafer Yamak Jan 20, 2022 6:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dead cat
Hussein Huda
Hussein Huda Nov 22, 2021 4:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dead stock
sadiq musa abubakar
sadiq musa abubakar Aug 03, 2021 2:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
who need coins I sale
sadiq musa abubakar
sadiq musa abubakar Aug 03, 2021 2:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mahmoud Abdo
Mahmoud Abdo Aug 02, 2021 10:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$20m upfront payment + Royalties + fixed fees = Boom
Richard Fortin
Richard Fortin Aug 02, 2021 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2-3$ then dump
Stephen Boyle
Stephen Boyle Jun 25, 2020 9:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like this one, all of the biotechs that treat inflammation have gone crazy. Chart showing some accumulation.
Stephen Boyle
Stephen Boyle Jun 25, 2020 9:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$2.92 close today.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email